Dr. Reshma Bhanushali, M.D
NPI: 1285892182
Total Payments
$5,952
2024 Payments
$1,202
Companies
43
Transactions
367
Medicare Patients
3,621
Medicare Billing
$356,451
Payment Breakdown by Category
Food & Beverage$5,800 (97.4%)
Education$152.38 (2.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,800 | 362 | 97.4% |
| Education | $152.38 | 5 | 2.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $755.15 | 48 | $0 (2024) |
| Lilly USA, LLC | $681.53 | 47 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $594.76 | 24 | $0 (2024) |
| PFIZER INC. | $587.57 | 31 | $0 (2024) |
| Amgen Inc. | $462.43 | 35 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $358.78 | 37 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $320.80 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $247.67 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $215.94 | 8 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $165.27 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,202 | 68 | AstraZeneca Pharmaceuticals LP ($187.14) |
| 2023 | $1,008 | 62 | AbbVie Inc. ($223.56) |
| 2022 | $887.11 | 59 | ABBVIE INC. ($260.93) |
| 2021 | $905.57 | 62 | Amgen Inc. ($163.94) |
| 2020 | $429.62 | 25 | Lilly USA, LLC ($130.17) |
| 2019 | $517.51 | 32 | Novartis Pharmaceuticals Corporation ($204.29) |
| 2018 | $651.78 | 42 | PFIZER INC. ($202.06) |
| 2017 | $349.70 | 17 | Astellas Pharma US Inc ($147.12) |
All Payment Transactions
367 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $21.06 | General |
| Category: Allergy/Immunology | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.48 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: NEUROSCIENCE | ||||||
| 09/23/2024 | Amphastar Pharmaceuticals, Inc. | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: GLYCOGENOLYTIC AGENTS | ||||||
| 09/09/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Neurology | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: VACCINES | ||||||
| 09/03/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 08/20/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: NEUROSCIENCE | ||||||
| 08/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Oncology | ||||||
| 08/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: PSYCHIATRY | ||||||
| 08/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: Endocrinology | ||||||
| 08/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: RESPIRATORY | ||||||
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardio-renal | ||||||
| 07/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 905 | 1,186 | $209,224 | $95,645 |
| 2022 | 19 | 909 | 1,197 | $215,051 | $87,652 |
| 2021 | 23 | 1,033 | 1,365 | $236,190 | $100,636 |
| 2020 | 19 | 774 | 876 | $189,915 | $72,519 |
Total Patients
3,621
Total Services
4,624
Medicare Billing
$356,451
Procedure Codes
78
All Medicare Procedures & Services
78 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 239 | 368 | $67,712 | $29,847 | 44.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 175 | 175 | $47,075 | $21,121 | 44.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 50 | 106 | $18,974 | $9,567 | 50.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 24 | 24 | $11,100 | $6,741 | 60.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 48 | 53 | $13,091 | $6,169 | 47.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 33 | $11,517 | $4,206 | 36.5% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 47 | 48 | $3,828 | $3,497 | 91.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 33 | 39 | $8,498 | $3,313 | 39.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 49 | $6,174 | $2,851 | 46.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 21 | 21 | $5,964 | $1,796 | 30.1% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 17 | 17 | $1,717 | $1,683 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 48 | $1,488 | $1,392 | 93.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 46 | 46 | $1,426 | $1,334 | 93.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 25 | $6,450 | $964.00 | 14.9% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 16 | 28 | $2,744 | $851.20 | 31.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 22 | 36 | $1,116 | $307.86 | 27.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 18 | 70 | $350.00 | $6.39 | 1.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 203 | 306 | $56,304 | $24,331 | 43.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 166 | 166 | $44,654 | $20,953 | 46.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 75 | 160 | $44,654 | $12,382 | 27.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 64 | 65 | $4,355 | $4,271 | 98.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 60 | $7,560 | $3,794 | 50.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 22 | $7,678 | $2,972 | 38.7% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 29 | 29 | $2,875 | $2,851 | 99.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 31 | 35 | $10,922 | $2,753 | 25.2% |
About Dr. Reshma Bhanushali, M.D
Dr. Reshma Bhanushali, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Lafayette, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/28/2008. The National Provider Identifier (NPI) number assigned to this provider is 1285892182.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Reshma Bhanushali, M.D has received a total of $5,952 in payments from pharmaceutical and medical device companies, with $1,202 received in 2024. These payments were reported across 367 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($5,800).
As a Medicare-enrolled provider, Bhanushali has provided services to 3,621 Medicare beneficiaries, totaling 4,624 services with total Medicare billing of $356,451. Data is available for 4 years (2020–2023), covering 78 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Internal Medicine
- Location Lafayette, LA
- Active Since 05/28/2008
- Last Updated 02/04/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1285892182
Products in Payments
- ENTRESTO (Drug) $393.95
- XARELTO (Drug) $358.78
- MOUNJARO (Drug) $285.23
- QULIPTA (Drug) $284.28
- ELIQUIS (Drug) $283.04
- EVENITY (Biological) $259.62
- FARXIGA (Drug) $204.78
- LEQVIO (Drug) $200.81
- CHANTIX (Drug) $169.38
- UBRELVY (Drug) $158.11
- JARDIANCE (Drug) $155.98
- TRULICITY (Drug) $147.16
- VYVANSE (Drug) $135.06
- EMGALITY (Drug) $134.15
- TRINTELLIX (Drug) $112.61
- VRAYLAR (Drug) $111.27
- Ozempic (Drug) $99.63
- SYNTHROID (Drug) $99.49
- FREESTYLE LIBRE 3 (Device) $98.34
- ImmunoCAP (Device) $90.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Lafayette
Dr. Kwong-Hon Chow, Md, Phd, MD, PHD
Student in an Organized Health Care Education/Training Program — Payments: $33,139
Student in an Organized Health Care Education/Training Program $33,139
James Hlavacek, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,950
Student in an Organized Health Care Education/Training Program $13,950
Michael Horaist, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $13,039
Student in an Organized Health Care Education/Training Program $13,039
Dr. Bradley Chastant, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $10,130
Student in an Organized Health Care Education/Training Program $10,130
Dr. James Rabalais, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $9,933
Student in an Organized Health Care Education/Training Program $9,933
Rafael Duran Vargas, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $8,138
Student in an Organized Health Care Education/Training Program $8,138